Figure 3From: Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysisFixed-effects model of risk ratio for a favorable outcome at three months: a comparison between magnesium sulphate infusion and a placebo in patients with aneurysmal subarachnoid hemorrhage [6, 11, 30].Back to article page